Online today this state of the art review in @BioDrugsJournal led by @wyatt_nic comprehensively summarising the literature around licensed and emerging treatments targeting leukocyte trafficking (integrins, S1P and MAdCAM-1) in #IBD. Free download here! rdcu.be/cy3oW
Celebrating #50YearsofDrugs in 2021. Delightful Editorial by Sir Graeme Avery, the founding publisher and first editor now online '50 Years on Still Relevant' bit.ly/3oMD07s